학술논문
Safety and Efficacy of Second-Line TKI Plus Anti-PD1 in Metastatic Non-Clear Cell Renal Cell Carcinoma: A Real-World Study
Document Type
Article
Author
Source
In Clinical Genitourinary Cancer April 2024 22(2):252-260
Subject
Language
ISSN
1558-7673